| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.75M | - | |
| Dir | 164.0K | $12.45M | -8,000 | |
| VP | 100.3K | $7.61M | - | |
| VP | 83.3K | $6.32M | -60,846 | |
| CFO | 82.7K | $6.27M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Wender Joseph H | Director | Sell | 16,800 | $65.50 | $1,100,384.88 | -15.4% | +20.0% | - | |
| Sep 30, 2025 | Hougen Elizabeth L55 | EVP, Finance &CFO | Sale+OE | 49,800 | $65.26 | $3,249,733.86 | -31.1% | +22.3% | - | |
| Sep 30, 2025 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 57,900 | $65.24 | $3,777,668.13 | -42.1% | +22.3% | - | |
| Sep 30, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 25,300 | $64.62 | $1,634,921.48 | -18.1% | +22.3% | - | |
| Sep 12, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 1,700 | $64.58 | $109,787.19 | -2.9% | +25.3% | - | |
| Sep 9, 2025 | Baroldi Joseph52 | EVP, Chief Business Officer | Sale+OE | 11,950 | $62.16 | $742,838.29 | -27.2% | +26.6% | - | |
| Sep 9, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 21,000 | $64.56 | $1,355,661.30 | -15.5% | +26.6% | - | |
| Sep 5, 2025 | Baroldi Joseph52 | EVP, Chief Business Officer | Sale+OE | 250 | $62.00 | $15,500.00 | -0.8% | +33.6% | - | |
| Sep 5, 2025 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sell | 6,000 | $59.60 | $357,580.80 | -6.8% | +33.6% | - | |
| Sep 3, 2025 | Monia Brett P60 | Chief Executive Officer | Sale+OE | 203,814 | $60.32 | $12,294,703.00 | -24.5% | +34.4% | - |